Neurotransmission unavoidably increases mitochondrial reactive oxygen species. However, the intrinsic antioxidant defense of neurons is weak and hence the mechanism whereby these cells are physiologically protected against oxidative damage is unknown. Here we found that the antioxidant defense of neurons is repressed owing to the continuous protein destabilization of the master antioxidant transcriptional activator, nuclear factor-erythroid 2-related factor-2 (Nrf2). By contrast, Nrf2 is highly stable in neighbor astrocytes explaining their robust antioxidant defense and resistance against oxidative stress. We also show that subtle and persistent stimulation of N-methyl-D-aspartate receptors (NMDAR) in astrocytes, through a mechanism not requiring extracellular Ca 2+ influx, upregulates a signal transduction pathway involving phospholipase C-mediated endoplasmic reticulum release of Ca 2+ and protein kinase Cδ activation. Active protein kinase Cδ promotes, by phosphorylation, the stabilization of p35, a cyclin-dependent kinase-5 (Cdk5) cofactor. Active p35/Cdk5 complex in the cytosol phosphorylates Nrf2 at Thr 395 , Ser 433 and Thr 439 that is sufficient to promote Nrf2 translocation to the nucleus and induce the expression of antioxidant genes. Furthermore, this Cdk5-Nrf2 transduction pathway boosts glutathione metabolism in astrocytes efficiently protecting closely spaced neurons against oxidative damage. Thus, intercellular communication through NMDAR couples neurotransmission with neuronal survival.
Neurotransmission unavoidably increases mitochondrial reactive oxygen species. However, the intrinsic antioxidant defense of neurons is weak and hence the mechanism whereby these cells are physiologically protected against oxidative damage is unknown. Here we found that the antioxidant defense of neurons is repressed owing to the continuous protein destabilization of the master antioxidant transcriptional activator, nuclear factor-erythroid 2-related factor-2 (Nrf2). By contrast, Nrf2 is highly stable in neighbor astrocytes explaining their robust antioxidant defense and resistance against oxidative stress. We also show that subtle and persistent stimulation of N-methyl-D-aspartate receptors (NMDAR) in astrocytes, through a mechanism not requiring extracellular Ca 2+ influx, upregulates a signal transduction pathway involving phospholipase C-mediated endoplasmic reticulum release of Ca 2+ and protein kinase Cδ activation. Active protein kinase Cδ promotes, by phosphorylation, the stabilization of p35, a cyclin-dependent kinase-5 (Cdk5) cofactor. Active p35/Cdk5 complex in the cytosol phosphorylates Nrf2 at Thr 395 , Ser 433 and Thr It is widely accepted that glutamatergic neurotransmission increases mitochondrial Ca 2+ uptake, which enhances reactive oxygen species (ROS) responsible for oxidative damage and neurodegeneration.
1,2 To defend themselves against ROS, neurons actively oxidize glucose through the pentosephosphate pathway (PPP), a metabolic route providing the NADPH(H + ) that is necessary for the regeneration of reduced glutathione (GSH) from its oxidized form (GSSG). 3, 4 To achieve this, neurons keep inhibited the glycolytic pathway by continuously degrading the key glycolytic-promoting enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) by the action of the E3 ubiquitine ligase anaphase-promoting complex/cyclosome and its cofactor Cdh1 (APC/C-Cdh1). 4 Although this strategy provides defense to neurons under resting conditions, the level of antioxidant protection under stressing conditions is transient and weak. 4 Thus, during activation of the synaptic ionotropic glutamate receptors, particularly the N-methyl-D-aspartate receptors (NMDAR) subtypes, neurons inhibit the FOXO target gene thioredoxin inhibitor Txnip hence increasing their antioxidant defenses. 5 However, overactivation of NMDAR in neurons, an excitotoxic phenomenon that underlies the pathogenesis of a number of neurological disorders, including Alzheimer's disease, Amyotrophic Lateral Sclerosis or stroke, 1,2 concomitantly inhibits the ubiquitylating activity of APC/C-Cdh1 (ref. 6 ) leading to PFKFB3 stabilization, glycolytic activation and PPP inhibition. 7 This metabolic reprograming caused by NMDAR activation compromises the efficacy of the antioxidant defense of neurons causing apoptotic death, at least when neurons are cultured alone. 7 Therefore, neurons should be provided with additional mechanism(s) aiding to combat the excess ROS they are continuously exposed.
Astrocytes are active players in neural signaling by efficiently removing excess glutamate at the synapse and modulating neurotransmission. 8 These glial cells are also essential for neuronal survival as they provide neurons with energy oxidative precursors, such as lactate. [9] [10] [11] Astrocytes are able to release GSH precursors, which neurons can use for the de novo GSH biosynthesis. 12 Accordingly, the presence of astrocyte cells surrounding neurons seems to be critical to keep neuronal functions, including neurotransmission, nutrients supply and antioxidant defense. However, the molecular mechanism that explains the extreme neuronal vulnerability to oxidative damage, as well as the mode whereby neurons dictates astrocytes to supply antioxidant protection, are unknown. The nuclear factor-erythroid 2-related factor-2 (Nrf2) is a master transcription factor that coordinates the cell antioxidant machinery. 13 However, whether Nrf2 has a function in astrocyte-mediated neuronal protection is a matter of debate. [14] [15] [16] [17] [18] Like postsynaptic neurons, astrocytes express ionotropic glutamate-receptor subtype NMDAR, 19 although their precise function in these glial cells is still enigmatic. In view that excess NMDAR activity, by inhibiting APC/C-Cdh1 in neurons, 6 leads to oxidative damage, 7 we sought to investigate whether astrocyte NMDAR, by sensing neurotransmission, would support neuronal survival. We found that Nrf2 is highly unstable in neurons due to continuous protein destabilization, which explains their high vulnerability to oxidative stress. Moreover, we showed that NMDAR activity in astrocytes boost a signaling pathway involving p35/Cdk5-mediated Nrf2 phosphorylation and activation that stimulates the release of GSH precursors for neuronal de novo GSH biosynthesis, hence sustaining neuronal antioxidant protection and survival.
Results
High Nrf2 destabilization explains weak antioxidant defense of neurons. To investigate Nrf2 regulation in brain cells, we first analyzed Nrf2 mRNA and protein levels, which were higher in primary astrocytes than in neurons of the rat cortex (Figures 1a and b; Supplementary Figure 1a) . Nrf2 is repressed by Kelch-like ECH-associated protein 1 (Keap1)-Cullin 3 (Cul3)-RING-box protein 1 (Rbx1), an E3 ubiquitin ligase that targets Nrf2 for proteasomal degradation.
13 Cul3 and Keap1 protein levels (Figure 1b; Supplementary Figure 1a) , as well as Cul3 mRNA (Supplementary Figure 1b) were higher in neurons than in astrocytes. As Cul3 is transcriptionally regulated by the signalosome, 20 we next analyzed the mRNA levels of the signalosome catalytic subunit Cop9S5, and those of the Cul3 assembly factor Cand1 (ref. 21 ) in neurons and astrocytes. As Cop9S5 and Cand1 mRNA levels were found similarly expressed in both cell types ( Supplementary Figures 1c and d) , a differential signalosome expression would unlikely explain the differences in Cul3 mRNA and Cul3 protein abundances in neurons versus astrocytes. We then sought to investigate whether the observed high Cul3 levels, by promoting Nrf2 degradation, explains the low Nrf2 protein abundance in neurons. Knocking down Cul3 by RNA interference led to Nrf2 stabilization in astrocytes (Figure 1c; Supplementary Figure 1e ) and in neurons (Figure 1d; Supplementary Figure 1f) . Thus, despite their considerably low abundance of Nrf2 mRNA, neurons translate it and subsequently degrade it. Accordingly, the relative abundances of Nrf2-target antioxidant genes glutamate-cysteine ligase, catalytic subunit (Gclc) and hemeoxygenase-1 (Ho-1) were lower in neurons than in astrocytes (Figure 1e ). Knocking down Cul3 in neurons accumulated Nrf2 protein to levels similar to those found in astrocytes (Figure 1f; Supplementary Figure 1g ), but their targets Gclc and Ho-1 mRNA levels did not (Figure 1g) . Inhibition of the proteasome with MG132 stabilized Nrf2 in astrocytes (Figure 1h; Supplementary Figure 1h ) and in neurons (Figures 1i-k; Supplementary Figures 1i-l) . These results show that, whereas neurons are equipped with a discrete Nrf2-regulated antioxidant system, the efficacy of its response is weak and inefficient when compared with that of astrocytes, suggesting the contribution of alternative mechanisms in neuroprotection.
NMDAR activity promotes functional activation of Nrf2 in astrocytes. We next sought to investigate whether astrocytes, through NMDAR, would sense glutamatergic neurotransmission to contribute in neuronal antioxidant defense. To test this hypothesis, astrocytes were incubated with low NMDA concentrations likely mimicking NMDAR physiological signaling. NMDA dose-dependently (1-100 μM) triggered a delayed, but sustained rise in cytosolic free Ca 2+ concentration ([Ca 2+ ] c ) in astrocytes (Figure 2a ). Although the occurrence of NMDAR in astrocytes has been debated, 19, 22 the constitutive expression of all NMDAR subunits, at different levels, including Nr1, Nr2a, Nr2b, Nr2c, Nr2d, Nr3a and Nr3b has been widely documented. [23] [24] [25] Likewise, we show that Nr1a, Nr2a and Nr2b mRNA (Supplementary Figure 1m) and Nr2a and Nr2b protein (Supplementary Figure 1n) are expressed in astrocytes under our circumstances. As from 50 μM, NMDA is considered neurotoxic, 5, 26 we used 20 μM NMDA thereafter as it triggered a similar [Ca permeability of NMDAR in astrocytes, as previously described. 27 Furthermore, incubation of astrocytes with NMDA (20 μM) in the absence of extracellular Ca 2+ ([Ca   2+ ] e.c. = 0) revealed increased [Ca 2+ ] c during a limited period, after which the sarco-ER Ca 2+ -ATPase inhibitor, thapsigargin, had no effect (Figure 2b) (Figure 2c ). These data indicate that the occurrence of the delayed increased [Ca 2+ ] c in NMDA-treated astrocytes has an ER origin. To further confirm that the observed intracellular Ca 2+ signal was a consequence of NMDAR activation, the natural NMDAR agonist, glutamate, was used. As shown in Supplementary  Figure 2 , glutamate was able to increase [Ca 2+ ] c in a manner that was prevented by MK801, a specific NMDAR antagonist, but not by CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), an AMPA/kainate receptor antagonist. Thus, astrocytes express functional NMDA receptors, the activation of which transduces a signaling mechanism leading to ER-derived cytosolic Ca 2+ increase. Astrocytes in culture often contain traces of other neural cell types, including neurons, microglia and oligodendrocytes that might putatively account for the observed NMDAR-mediated changes in free cytosolic Ca 2+ . However, all our experiments were performed in astrocytes that were reseeded after overnight shaking to remove loosely attached cells, such as neurons (Map2 Figure 3c) . Sustained (8 h) incubation of astrocytes with NMDA (20 μM) upregulated Nrf2-target genes Gclc, Ho-1 and NADPH quinone oxidorreductase-1 (Nqo1; Figure 2d ). This was a consequence of NMDA acting on its receptors, as MK801 abolished this effect (Figure 2d ). Moreover, this was an Nrf2-dependent process, as Nrf2 knockdown (Figures 2e and f; Supplementary Figure 3d) prevented the increase in Nrf2-target genes expression (Figure 2g ). To further confirm these results, we next assessed Nrf2 protein abundance and subcellular localization after NMDA treatment, and we found an increase (Figure 2h Figure 4c) . Furthermore, neurons were separated from astrocytes by flow cytometric cell sorting, using the plasma membrane astrocytic-specific antibody anti-integrin-β5 (Supplementary Figure 4d) . Western blotting of the β5-integrin-negative cell subpopulation (astrocyte-free neurons, as revealed by neuron-specific βIII-tubulin) demonstrated that neurons accounted for the MG132-mediated increase in Nrf2 protein (Supplementary Figure 4d) . Altogether, our results show that, although neurons are able to stabilize Nrf2 during proteasomal inhibition, astrocytes account for the vast majority of Nrf2 abundance of these two cell types. Furthermore, we show that subtle NMDAR activation in astrocytes compatible with physiological neurotransmission triggers a functional Nrf2-mediated antioxidant response in astrocytes.
Stimulation of NMDAR promotes Cdk5-mediated Nrf2 phosphorylation and activation. We next aimed to understand the molecular mechanism responsible for the NMDARdependent stimulation of Nrf2 pathway in astrocytes. In view that Nrf2 contains several potential consensus phosphorylation sites by multiples protein kinases (http://scansite.mit.edu/), we asked whether NMDAR activity triggered Nrf2 phosphorylation. Immunoprecipitation of Nrf2 followed by western blotting against an anti-Ser antibody revealed Nrf2 phosphorylation by NMDAR activation both in astrocytes (Figure 3a Figure 5c ). We previously reported that excitotoxic NMDAR activation in neurons triggers Ca 2+ -mediated, p25-dependent, cyclin-dependent kinase-5 (Cdk5) activation. 6 Thus, we searched for putative Cdk5 consensus motifs in the Nrf2 sequence, and found at least three high-score potential Cdk5-target residues, namely Thr 395 (VKQNGPKTPVHSSGD), Ser 433 (PEKELPVSPGHRKTP) and Thr 439 (VSPGHRKTPFTKDKH; http://scansite.mit.edu/). We therefore hypothesized whether Cdk5 would be responsible for Nrf2-mediated phosphorylation upon NMDAR stimulation. We found that both extracellular and intracellular Ca NMDAR-mediated transduction pathway leading to Nrf2 activation in astrocytes. To further get insight into the mechanism whereby NMDAR activates Cdk5 leading to Nrf2 phosphorylation in astrocytes, we first assessed the possible conversion of Cdk5-cofactor, p35, into p25, a phenomenon that we previously reported in neurons during excitotoxicity (100 μM NMDA). 6 However, we found that neither incubation . Thus, physiologic-like stimulation of NMDAR does not promote the p25/Cdk5 activation that takes place during excitotoxicity. 6 To test whether Cdk5 was active in astrocytes treated with physiologic-like NMDA concentrations, we fractionated nuclei and cytosol, which were subjected to an in vitro Cdk5 activity assay. As shown in Figure 4c ( Supplementary Figure 7a) , Cdk5-immunoprecipitated cytosol -but not nuclei extracts -was able to phosphorylate histone H1. This indicates that Cdk5 remains active in the cytosol, a result consistent with the physiologic p35/Cdk5 activity. 29 We next performed an in vitro Nrf2 phosphorylation assay by p35/Cdk5 in either wild-type Nrf2, or in a site-directed T395A/S433A/T439A-mutant Nrf2 form. As depicted in Figure 4d , (Supplementary Figure 7b) p35/ Cdk5 phosphorylated the wild type, but very weakly the T395A/S433A/T439A mutant form of Nrf2 showing that Nrf2 is a p35/Cdk5 substrate, although additional p35/Cdk5-phosphorylation site(s) may occur in Nrf2. To investigate the subcellular localization of Nrf2 upon NMDAR activation, we then transfected astrocytes with either wild type or T395A/ S433A/T439A mutant forms of Nrf2 fused with green fluorescent protein (GFP). As shown in Figure 4e ( Supplementary Figure 7c) , NMDA induced accumulation of wild type, but not T395A/S433A/T439A mutant Nrf2-GFP. Moreover, we observed that although wild-type Nrf2 was Figure 7d) . GFP immunofluorescence imaging in astrocytes confirmed these effects (Figure 4g ). Thus, sustained -otherwise physiologiclike -NMDAR signaling in astrocytes promotes p35/Cdk5-mediated Nrf2 phosphorylation and nuclear translocation. Then, we aimed to decipher the transduction pathway leading to p35/Cdk5 activation upon NMDAR signaling in astrocytes. In view that protein kinase Cδ (PKCδ) phosphorylates p35 sustaining its stability, 30 we used compound U73122 (and its inactive isomer, U73343) 31 to antagonize PKCδ upstream step, phospholipase C (PLC), and rottlerin to inhibit PKCδ directly. 32 We found that NMDAR-mediated p35 phosphorylation (Figure 4h Altogether, these results indicate that NMDAR activation in astrocytes promotes PLC activation through a mechanism that does not require extracellular Ca 2+ influx. Active PLC, which triggers a delayed cytosolic Ca 2+ rise by promoting its release from the ER, activates PKCδ that, in turn, phosphorylates p35 to keep Cdk5 active in the cytoplasm to sustain Nrf2 phosphorylation and functional activation.
The NMDAR-Cdk5-Nrf2 pathway in astrocytes sustains antioxidant protection and survival of neurons. To ascertain if our results had physiological significance, we sought to investigate whether NMDAR-mediated enhancement of antioxidant Nrf2 response in astrocytes functionally resulted in neuronal antioxidant protection. Incubation of neurons with 20 μM NMDA for 8 h did not change GSH concentration (Figure 5a ), confirming that the stimulation of Nrf2 pathway in neurons is insufficient to improve antioxidant status. However, NMDA (20 μM, 8 h) did enhance the GSH concentrations in astrocytes (Figure 5b ). Then, we asked whether NMDAR signaling, by stimulating the Cdk5-Nrf2 pathway in astrocytes herein described, would meet the neuronal demands for GSH during neurotransmission. To achieve this, we performed astrocyte-neuronal co-cultures that were incubated in the presence of NMDA (20 μM, 8 h); after this incubation period, neurons were separated from the astrocytes and analyzed. As shown in Figure 5c , GSH concentration in neurons increased by approximately threefold in coculture with astrocytes; interestingly, NMDA, which in neurons alone did not alter GSH concentrations (Figure 5a ), promoted an approximately threefold increase in neuronal GSH concentrations in co-culture with astrocytes ( Figure 5c ). This was a Cdk-dependent effect as the presence of roscovitine in the co-culture prevented NMDAR-mediated increase in neuronal GSH (Figure 5c ). Moreover, acivicin, an inhibitor of γ-glutamyltransferase 33 that catalyzes the release of GSH precursors from astrocytes, prevented NMDAR-mediated increase in neuronal GSH (Figure 5d ). Thus, NMDAR signaling in astrocytes triggers the release of GSH precursors that lead to increased GSH concentrations in neighboring neurons.
Finally, we sought to ascertain whether the astrocyteneuronal supply of GSH precursors influenced neuronal vulnerability against oxidative stress. As shown in Figure 5e , incubation of neurons with H 2 O 2 , after co-cultured with astrocytes, promoted apoptotic neuronal death. However, apoptosis was abolished by the presence of NMDA during coculture, an effect that was rescued by acivicin (Figure 5e ). Thus, GSH precursors availability and survival of neurons following astrocyte NMDAR signaling depends on astrocytederived GSH precursors supply to neurons. To assess if neuronal protection by astrocyte NMDAR signaling depends on the Cdk5-Nrf2 transduction pathway, we knocked down Nrf2 (Figures 2e and f) or Cdk5 (Figure 3c ) in astrocytes before they were co-cultured with neurons. As shown in Figures 5f and g, Nrf2 or Cdk5 knockdown, respectively, in astrocytes abolished the neuroprotective effect of NMDAR signaling. Moreover, a decrease in neuronal Δψ m was observed by H 2 O 2 , but this was abolished by NMDA during the co-culture (Figure 5h ). Finally, the increased H 2 O 2 formation triggered by an excitotoxic insult (glutamate 100 μM/15 min) to neurons was prevented by NMDA in the astrocyte-neuronal co-culture (Figure 5i) . However, the knockdown of Nrf2 or Cdk5 in astrocytes, before co-cultured with neurons, were unable to rescue NMDA-mediated protection against excitotoxic-induced neuronal H 2 O 2 formation (Figure 5i) . Thus, the Cdk5-Nrf2 transduction pathway in astrocytes during NMDAR signaling sustains antioxidant protection and survival of neurons.
Discussion
During neurotransmission, neurons unavoidably trigger ROS production, but their weak antioxidant defense does not meet protection. Here we show that NMDAR activity in astrocytes (e) Incubation of neurons, after the 8 h co-incubation period with astrocytes, with H 2 O 2 (400 μM) increased neuronal apoptotic death, determined after 1 h; the presence of NMDA (20 μM) during co-incubation yielded neurons resistant to the H 2 O 2 insult; however, this resistance was lost by acivicin. (f) Incubation of neurons, after the 8 h co-incubation period with astrocytes, with H 2 O 2 (400 μM) increased neuronal apoptotic death (after 1 h) if astrocytes in co-culture were transfected with a siControl, but the presence of NMDA (20 μM) during the co-culture prevented this effect; however, Nrf2 knockdown (siNrf2) in astrocytes before the co-culture was unable to prevent H 2 O 2 -induced neuronal apoptotic death, regardless the presence of NMDA during co-culture. (g) Incubation of neurons, after the 8 h co-incubation period with astrocytes, with H 2 O 2 (400 μM) increased neuronal apoptotic death (after 1 h) if astrocytes in co-culture were transfected with a siControl, but the presence of NMDA (20 μM) during the co-culture prevented this effect; however, Cdk5 knockdown (siCdk5) in astrocytes before the co-culture was unable to prevent H 2 O 2 -induced neuronal apoptotic death, regardless of the presence of NMDA during co-culture. (h) Incubation of neurons, after the 8-h co-incubation period with astrocytes, with H 2 O 2 (400 μM) decreased neuronal mitochondrial inner membrane potential (Δψ m ), determined after 1 h, an effect that was abolished if NMDA (20 μM) was present during the astrocyte-neuronal co-culture incubation period. (i) After 8 h of neuronal co-culture with astrocytes (either in the absence or in the presence of NMDA 20 μM), astrocytes were removed, and neurons alone were further incubated (or not) with glutamate (100 μM/15 min, followed by 1 h in DMEM; post treatment with an excitotoxic insult); this excitotoxic insult increased H 2 O 2 , an effect that was prevented if NMDA was present during the co-culture period; however, NMDA was unable to prevent excitotoxic-induced H 2 O 2 increase if Nrf2 or Cdk5 were knocked down (siNrf2 or siCdk5) in astrocytes before the co-culture. Data are expressed as mean ± S.E.M. *Po0.05 (Student's t-test for a-c, e-h; ANOVA followed by Bonferroni test for d and i; n = 3-4 independent experiments) exerts neuronal antioxidant protection, and we provide a signaling pathway for this effect (Supplementary Figure 8) . Thus, astrocytes, by sensing glutamatergic neurotransmission through their NMDAR, sustain a PLC-PKCδ-mediated p35/ Cdk5-Nrf2 transduction pathway that allows neurons to receive GSH precursors for the endogenous de novo biosynthesis. We also show that, though weakly, the Nrf2 system occurs in neurons where it is amenable by NMDARdependent upregulation; however, it is insufficient to provide self-protection, even if astrocytes are present. Thus, our results may explain the enigma of the very weak antioxidant capacity of neurons. 34 We also observe that the release of Ca 2+ from the ER participates in Nrf2 phosphorylation upon NMDAR activation in astrocytes. However, as PKCδ is Ca 2+ insensitive, 35 but amenable to activation by diacylglycerol 35 -the PLC activity product -we propose that PKCδ is activated by DAG upon NMDAR activation. Therefore, our data strongly suggest that NMDAR, at least in astrocytes, transduce a metabotropic-like signal. However, understanding the specific mechanism of its occurrence remains to be elucidated. The specific function played by ER-released Ca 2+ in the signaling cascade leading to Nrf2 phosphorylation also remains apparently obscure. However, it should be mentioned that, at least in neurons, ERreleased Ca 2+ exerts a positive feedback activation loop on PLC. 36 Provided this phenomenon also occurs in astrocytes upon NMDAR activation, we hypothesize that it would allow sustaining a positive loop of PLC-mediated PKCδ activation, thus keeping Nrf2 continuously active during long periods of neurotransmission. Moreover, Nrf2 is known to be phosphorylated at S40 by PKCδ, 37 although this is necessary, but not sufficient, to promote Nrf2 nuclear translocation. Our data therefore support a critical role for PKCδ in astrocyte Nrf2-mediated antioxidant response, as it would coordinate a permissive Nrf2-S40 phosphorylation, with an active p35/ Cdk5-mediated Nrf2-T395/S433/T439 phosphorylation. Whether this Cdk5-Nrf2 transduction pathway accounts for neuroprotection during ischemic preconditioning 18 is a tempting possibility yet to be determined. However, the fact that ischemic preconditioning may be dependent on astrocyte Nrf2 transcriptional activity 18 strongly supports this notion. Our results also support the notion that astrocytes are active players in neurotransmission. Thus, astrocytes are critical for neuronal function by actively modulating neuronal receptors. 38 However, upon neuronal activity, astrocytes can supply metabolic substrates, such as lactate, which neurons can use for energy provision 39, 40 as well as for modulating neurotransmission. 41 Here we now decipher a molecular mechanism that explains the link between neuronal synaptic activity with astrocyte provision of antioxidant precursors to sustain neuronal survival. Whether this NMDAR-p35/Cdk5 pathway would also account for lactate provision from astrocytes to neurons 39, 40 remains a tempting possibility yet to be explored. Furthermore, the involvement of Cdk5 as a key player in this process suggests additional function(s) for this antioxidant pathway. Thus, Cdk5-Nrf2 signaling seems to be ubiquitous, in view of its occurrence in neurons besides astrocytes. Nrf2 is also elevated in cancer cells, 13, 42, 43 hence it is tempting to speculate that Cdk5 -which contributes to cancer progression 44 -would sustain Nrf2-mediated antioxidant activity and survival of rapidly proliferating cells.
Materials and Methods
Ethical use of animals. Rats were bred at the Animal Experimentation Unit of the University of Salamanca, and all protocols were approved by the Bioethics Committee of the University of Salamanca in accordance with the Spanish legislation (RD53/2013).
Cell cultures and co-cultures. Primary cultures of rat cortical neurons were prepared from fetal Wistar rats of 16 days of gestation, 45 seeded at 2.5 × 10 5 cells/ cm 2 in different size plastic plates coated with poly-D-lysine (15 μg/ml) and incubated in DMEM (Sigma, Madrid, Spain) supplemented with 10% fetal calf serum (FCS; Roche Diagnostics, Heidelberg, Germany). Cells were incubated at 37°C in a humidified 5% CO 2 -containing atmosphere. At 48 h after plating, the medium was replaced with DMEM supplemented with 5% horse serum (Sigma), 20 mM D-glucose and, on day 4, cytosine arabinoside (10 μM) to prevent non-neuronal proliferation. Cells were used for the experiments on day 6 in vitro (DIV). Rat cortical astrocytes in primary culture were obtained from 0 to 24-h-old neonates, and cell suspension seeded at 2.5 × 10 5 cells/cm 2 in DMEM supplemented with 10% FCS in 175 cm 2 plastic flasks. To detach non-astrocytic cells, after 1 week in vitro, the flasks were shaken at 200 r.p.m. overnight, the supernatant discarded and the attached, astrocyte-enriched cells, were reseeded in different size plates. To obtain astrocyteneuronal co-culture, astrocytes were reseeded on 10 cm 2 inserts (0.4 μm pore size, Millipore Merck, Darmstadt, Germany) and allowed to attach for 24 h. After this time, astrocytes were treated, or not, before the inserts were co-cultured with 6 DIV neurons. Human embryonic kidney-293 T (HEK293T) cells were maintained in DMEM supplemented with 10% (v/v) FCS. Twenty-four hours before the experiment, the cells were reseeded at 1.8 × 10 5 cells/cm 2 in plates previously coated with poly-D-lysine (15 μg/ml).
Plasmids constructions and site-directed mutagenesis. Human Nrf2 full-length cDNA (1,817 pb, accession number, NM_006164.3; plasmid pT-REx-DEST30) was purchased from Source Bioscience (Nottingham, U.K.) and subcloned in pEGFP-C1 vector (Invitrogen) in phase with the full-length cDNA encoding the green fluorescent protein (GFP) at Nrf2 5'-terminus using the forward and reverse oligonucleotides, respectively, 5′-CGGGATCCGCGATGATGGACTTG GAGCTGCCGCCGCCGGGA-3′ and 5′-CGGGATCCGCGCTAGTTTTTCTTAACA TCTGGCTTCTTACT-3′ (BamHI sites underlined), which were purchased from Thermo Scientific (Offenbach, Germany), and then sequence verified. This GFPNrf2 cDNA fusion construct was then subjected to site-directed mutagenesis on T395, S433 and T439, which were replaced by Ala or Asp residues to obtain the phosphodefective (Nrf2-A) and phosphomimetic (Nrf2-D) forms or Nrf2, respectively, using QuikChange XL kit (Stratagene, La Jolla, CA, USA), followed by DpnI digestion. The forward and reverse oligonucleotides designed for this mutation were, respectively, 5′-AACAGAATGGTCCTAAAGCACCAGTACATTCTTCTG-3′ and 5′-CAGA AGAATGTACTGGTGCTTTAGGACCATTCTGTT-3′ for T395A; 5′-ATTGCCTGTAGC TCCTGGTCATCGGAAAGCCCCATTCAC-3′ and 5′-GTGAATGGGGCTTTCCGAT GACCAGGAGCTACAGGCAAT-3′ for S433A/T439A; 5′-ACAGAATGGTCCTAAA GATCCAGTACATTCTTCTGG-3′ and 5′-CCAGAAGAATGTACTGGATCTTTAGGAC CATTCTGT-3′ for T395D; 5′-GAGAAAGAATTGCCTGTAGATCCTGGTCATCGGAA AACCC-3′ and 5′-GGGTTTTCCGATGACCAGGATCTACAGGCAATTCTTTCTC-3′ for S433D; and 5′-ATCCTGGTCATCGGAAAGACCCATTCACAAAAGA-3′ and 5′-TCTTTTGTGAATGGGTCTTTCCGATGACCAGGAT-3′ for T439D. For Nrf2 protein purification, the Nrf2 cDNA was fused, on its 5′-terminus, with the fulllength cDNA encoding glutathione-S-transferase (GST) in pGEX-2 T vector (GE Healthcare Life Science, Barcelona, Spain), expressed in Bcl2 bacteria strain, and purified using GSH-sepharose beads.
Small interference RNA. To obtaine specific protein knockdown, we used the following small interference RNA (siRNAs; only the forward strand shown), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), 5´-CUGUUGAUGACUUCAAUGA-3( nucleotides 1473-1492 for rat NM_031789); cullin3 (Cul3), 5´-UGACAGA AAACACGAGAUA-3´(nucleotides 2031-2050 for rat NM_001106923); cyclindependent kinase-5 (Cdk5), 5´-AAGCCGUACCCGAUGUAUC-3´(nucleotides 859 -877 for rat NM_080885). 46 In all cases, an siRNA against luciferase (5′-CUGACGCGGAAUACUUCGAUU-3′) was used as control siRNA (siControl). 47 Annealed siRNAs were purchased from Dharmacon (Abgene, Thermo Fisher, Epsom, UK).
Cell treatments. All transfections with plasmids of primary cultures were performed using either Lipofectamine 2000 or Lipofectamine LTX+Reagent Plus (Invitrogen, Madrid, Spain), following the manufacturer's instructions. Astrocytes and neurons were transfected with 0.16-1.6 g/ml of the plasmid vectors at 12-14 DIV or 5 DIV, respectively, and used on the following day. HEK293T we transfected using 1 μM polyethylenimine (PEI, Sigma). Transfections of astrocytes or neurons with siRNAs were performed using Lipofectamine RNAiMAX (Invitrogen) following the manufacturer's instructions and used after 72 h. According to the degree of protein knockdown consistently observed by this procedure, the efficiency of transfection of siRNAs is estimated to be 80-90%. To activate NMDA receptors, cells were incubated with different concentrations of NMDA (1-100 μM; Sigma catalog number M3262) for 8-24 h in DMEM without FCS. Where indicated, incubations were performed in the presence of MK801 (10 μM; Sigma), roscovitine (10 μM; Sigma), MDL (100 μM; Calbiochem, Darmstadt, Germany), rottlerin (25 μM; Santa Cruz Biotechnologies, Heidelberg, Germany), U73122 (10 nM; Millipore), U73343 (10 nM; Millipore), acivicin (100 μM; Santa Cruz Biotechnologies), EGTA (100 μM in Ca 2+ -free DMEM; Sigma), BAPTA (10 μM; Calbiochem), tert-butylhydroquinone (tBHQ, 20 μM; Sigma), MG132 (10 μM; Calbiochem), actinomycin D (ActD, 100 ng/ml; Sigma) or H 2 O 2 (400 μM). To promote an excitotoxic insult, neurons were incubated with 100 μM glutamate plus 10 μM glycine in buffered Hank's solution (134.2 mM NaCl, 5.26 mM KCl, 0.43 mM KH 2 PO 4 , 4.09 mM NaHCO 3 , 0.33 mM Na 2 HPO 4 , 5.44 mM glucose, 20 mM HEPES, 4 mM CaCl 2 , pH 7.4) 48 ; after 15 min, the buffer was removed and cells further incubated for 1-4 h in DMEM without FCS. Subcellular fractionation. To fractionate cytosol from nucleus, cells were washed with cold phosphate-buffered saline (PBS) containing 1 mM MgCl 2 , harvested with cytosolic buffer (10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM EDTA, NP-40 0.1%, v/v, 1.5 M sucrose and protease and phosphatase inhibitors cocktail, pH 7.9 ), triturated with a micropipette to promote cell lysis, left on ice for 30 min and vortexed for 10 s. After checking cell lysis under a light microscope, extracts were centrifuged at 830 × g for 10 min and the cytosolic fraction (supernatant) was removed and boiled for 5 min. Lysis of the nuclei was performed by resuspending the nuclear pellet in nuclear buffer (50 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl mM, 0.5 mM NaCl, 1 mM EDTA, NP-40 1%, v/v, and protease and phosphatase inhibitor cocktail, pH 7.9), triturated with a micropipette, left on ice for 2 h, vortexed (10 s), boiled (5 min) and sonicated (5 min).
Western blotting. Cells or subcellular fractions were lysed in RIPA buffer (2% sodium dodecylsulphate, 2 mM EDTA, 2 mM EGTA and 50 mM Tris pH 7.5), supplemented with phosphatase inhibitors (100 μM phenylmethylsulfonyl fluoride, 50 μg/ml antipapain, 50 μg/ml pepstatin, 50 μg/ml amastatin, 50 μg/ml leupeptin, 50 μg/ml bestatin, 1 mM o-vanadate, 50 mM NaF and 50 μg/ml soybean trypsin inhibitor) and boiled for 5 min. Extracts were centrifuged at 13,000xg for 5 min at 4°C, and aliquots of lysates (50 μg protein, unless otherwise stated) were subjected to SDS-polyacrylamide (SDS-PAGE) electrophoresis on a 8, 10 or 12% acrylamide gel (MiniProtean, Bio-Rad, Hercules, CA, USA) including BenchMark (Invitrogen) or Dual Colors (Bio-Rad) as prestained protein ladders. The resolved proteins were transferred electrophoretically to nitrocellulose membranes (Hybond-ECL, Amersham Bioscience Europe, Barcelona, Spain). Membranes were blocked with 5% (w/v) low-fat milk in 20 mM Tris, 500 mM NaCl and 0.1% (w/v) Tween 20, pH 7.5, for 1 h. After blocking, the membranes were immunoblotted with primary antibodies at dilutions ranging from 1:200 to 1:1000 overnight at 4ºC. After incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnologies), goat anti-mouse IgG (Santa Cruz Biotechnologies), or rabbit anti-goat IgG (Santa Cruz Biotechnologies; all at 1:10,000 dilution), membranes were immediately incubated with the enhanced chemiluminescence kit SuperSignal West Dura (Pierce, Thermo Scientific, Rockford, IL, USA) for 5 min or Immobilon Western Chemiluminiscent HRP Substrate (Merck Millipore) for 1 min, before exposure to Kodak XAR-5 film for 1-5 min, and the autoradiograms scanned. Biologically independent replicates (two to four) were always performed, and a representative western blot is shown. The protein abundances were measured by densitometry of the bands on the films using ImageJ 1.48u4 software (National Institutes of Health, USA), and were normalized against the corresponding loading control.
Primary antibodies for western blotting. Immunoblotting was performed using mouse monoclonal anti-Gapdh (AM4300, Ambion, Austin, TX, USA), mouse monoclonal anti-β-actin (A3854, Sigma), rabbit polyclonal anti-βIII-tubulin (ab18207, Abcam), rabbit polyclonal anti-Nup98 (2292, Cell Signaling, Boston, MA, USA), mouse monoclonal anti-lamin B (sc374015, Santa Cruz Biotechnologies), mouse monoclonal anti-Map2 (M2320, Sigma), rabbit polyclonal anti-Gfap (G9269, Sigma), goat polyclonal anti-Nrf2 (sc30915, Santa Cruz Biotechnologies), mouse monoclonal anti-Keap1 (60027-1-lg, ProteinTech), rabbit monoclonal anti-Cul3 (ab75851, Abcam), rabbit polyclonal anti-Cdk5 (sc-173, Santa Cruz Biotechnologies), rabbit polyclonal anti-p35 (sc-820, Santa Cruz Biotechnologies), rabbit polyclonal anti-phosphoserine (61-8100, Invitrogen), rabbit polyclonal anti-GFP (ab6556, Abcam), β5-integrin (14-0497, eBioscience), anti-Nr2a and anti-Nr2b (generously donated by A. Fernandez-Lopez, University of Leon, Spain). 49 Immunoprecipitation assay. For immunoprecipitation of endogenous proteins, neurons and astrocytes were lysed in RIPA buffer supplemented with the phosphatase and protease inhibitor cocktail indicated above. Cell extracts were clarified by centrifugation, and the supernatants (100-200 μg protein) were incubated with anti-Nrf2 (1 μg), anti-Cdk5 (2 μg) or anti-p35 (1 μg) for 4 h at 4 ºC, followed by the addition of 30 μl of protein A-agarose (GE Healthcare Life Sciences, Uppsala, Sweden) for 2 h at 4 ºC. Inmunoprecipitates were extensively washed with lysis buffer and detected by western blot analysis. 
Cytosolic Ca
2+ determination using Fura-2 fluorescence. To monitor intracellular free Ca 2+ concentrations ([Ca 2+ ] c ) astrocytes growing on coverslips were incubated with Fura-2/AM (4 μM) at 23-25°C for 40 min in a Na + -Hepes buffer containing (in mM), 140 NaCl, 4.7 KCl, 1.3 CaCl 2 , 2 MgCl 2 , 10 mM Hepes, 10 mM glucose and 0.2% (w/v) bovine serum albumin (pH, 7.4). 50 After the extracellular medium was discarded, it was replaced with fresh Na + -HEPES buffer without Fura-2/AM and cells were immediately used. Coverslip-containing cells were mounted on an experimental perfusion chamber and placed on the stage of an epifluorescence inverted microscope (Nikon Diaphot T200, Melville, NY, USA). For fura-2 fluorescence changes determination, an image acquisition and analysis system for video microscopy was employed (Hamamatsu Photonics, Hamamatsu, Japan). Cells were alternatively excited at 340/380 nm with light from a xenon arc lamp passed through a high-speed monochromator (Polychrome IV, Photonics, Hamamatsu, Japan). Fluorescence emission at 505 nm was detected using a cooled digital CCD camera (Hisca CCD C-6790, Hamamatsu, Japan) and recorded using dedicated software (Aquacosmos 2.5, Hamamatsu Photonics). Under these conditions, Fura-2-emitted fluorescence closely reflects changes in [Ca 2+ ] c , 51 and the results are expressed as the ratio of fluorescence emitted at both excitation wavelengths (previously normalized to the resting fluorescence). Stimuli were dissolved in the extracellular Na-HEPES buffer and applied directly to the cells in the perfusion chamber. In the experiments where Ca 2+ free medium was employed, Ca 2+ was omitted from the extracellular solution and 500 μM EGTA was added to the medium. Intracellular-free Ca 2+ concentrations in neurons were estimated by recording the Fura-2-emitted fluorescence using a Varioskan Flash (Thermo Fischer, Vantaa, Finland) spectrofluorometer in cells seeded in 96-wells plates. Biologically independent replicates (two to five replicas of 40-60 cells each) were performed, but a representative record is shown. In some experiments, [Ca 2+ ] c were determined in pooled astrocytes in suspension loaded with fura-2-AM (4 μM) at room temperature (23-25°C) for 40 min. Changes in fluorescence signals were monitored by placing aliquots of dye-loaded cells into a cuvette in a fluorescence spectrofluorimeter (RF-5001-PC; Shimadzu, Kyoto, Japan) with continuous stirring at 37 ºC. Cells were then excited alternatively at 340 and 380 nm, and fluorescence Determination of GSH concentrations. Cells were lysed with 1% (w/v) of sulfosalicylic acid, centrifuged at 13,000xg for 5 min at 4°C, and the supernatants were used for the determination of total GSH (i.e., reduced GSH concentration plus twice the concentration of oxidized GSH), using GSSG (0-50 μM) as standard as described previously. 52 Total GSH was measured in reaction buffer (0.1 mM NaHPO 4 , 1 mM EDTA, 0.3 mM DTNB, 0.4 mM NADPH, GSH reductase 1 U/ml, pH 7.5) by recording the increase in the absorbance after the reaction of reduced GSH with DTNB for 2.5 min at 15 s intervals using a Multiskan Ascent (Thermo Electron Corp, Basingstoke, United Kingdom) spectrophotometer (excitation: 405 nm).
Flow cytometric analysis of apoptotic cell death. Cells were carefully detached from the plates using 1 mM EDTA (tetrasodium salt) in PBS (pH 7.4). APC-conjugated annexin-V and 7-amino-actinomycin D (7-AAD) (Becton Dickinson Biosciences, Bergen, NJ, USA) were used to determine quantitatively the percentage of apoptotic neurons by flow cytometry. Cells were stained with annexin-V-APC and 7-AAD in binding buffer (100 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 ), according to the manufacturer's instructions, and 5 × 10 4 cells were analyzed, in three replicates per condition, on a FACScalibur flow cytometer (15 mW argon ion laser tuned at 488 nm; CellQuest software, Becton Dickinson Biosciences). Annexin + and 7-AAD − cells were considered apoptotic. The analyzer threshold was adjusted on the flow cytometer channel to exclude most of the subcellular debris in order to reduce the background noise owing to the neurite disruption during neuronal detaching. Data were expressed as percentages.
Flow cytometric detection of Map2 and Gfap. To characterize primary neuronal cultures, cells were fixed and permeabilized using the Fix&Perm kit (BD) and incubated with anti-Map2 (neuronal marker) and Gfap (glial marker) antibodies at 4°C overnight. On the next day, the cells were incubated with the secondary Cy2 and Cy3-conjugated antibodies, respectively, for 1 h at room temperature and analyzed in the cytometer using FL1 and FL3 channels, respectively.
Cell sorting. Cortical neurons in primary culture were carefully detached with tetrasodium EDTA 1 mM in PBS (pH 7.4) and incubated with an anti-integrin β5 (a plasma membrane specific astrocyte marker) 53 antibody at 4°C overnight. On the next day, cells were incubated with the secondary Alexa 488-conjugated IgG mouse antibody for 1 h at room temperature, and then resuspended in 500 μl of PBS for analysis using a FACSAria III cell sorter (BD Biosciences). Integrin-β5 + and integrin-β5 − cells were collected in different tubes and lysed with RIPA buffer for western blot analysis.
In vitro p35/Cdk5 kinase assay. Neurons were lysed in ice-cold buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM EDTA, 2 mM EGTA, 1% NP-40, supplemented with the phosphatase and protease inhibitor cocktail cited above. After clearing debris by centrifugation, extracts (500 μg protein) were incubated with anti-Cdk5 (2 μg) for 4 h at 4 ºC, followed by the addition of 30 μl of protein A-sepharose (GE Healthcare Life Sciences, Uppsala, Sweden), for 2 h at 4 ºC. Immunoprecipitates were washed for four times in lysis buffer and resuspended in kinase buffer (20 mM Tris-HCl pH 7.6, 20 mM MgCl 2 , 2 mM MnCl 2 , 1 mM EDTA, 1 mM EGTA, 0.1 mM dithiothreitol) containing 50 μM ATP, 2 μCi of [γ- 32 P]ATP and histone H1 (1 mg/ml; Sigma). Samples were subjected to SDSpolyacrylamide gel (12%) electrophoresis and transferred proteins were visualized by autoradiography or blotted with anti-Cdk5. 54 GST-Nrf2 wild type and GST-Nrf2 mutant (phosphodefective) were expressed in 10 ml of Bl21 culture medium after 500 μM isopropyl-β-D-thiogalactopyranoside induction for 4 h at 37 ºC. Then, the cells were collected by centrifugation and resuspended in lysis buffer (PBS, Triton-X-100 1% v/v, lysozyme 0.2 μg/ml, DTT 2 mM y protease inhibitors PMSF 1 mM, aprotinin 10 μg/ml y leupeptin 10 μg/ml). After incubation of the cell suspension at 4°C for 30 min, it was sonicated (Misonic XL2010), and centrifuged at 30,000 × g at 4°C for 30 min. The supernatants were purified on 200 μl of GSH-agarose beads (GE Healthcare Life Sciences) at 4°C for 2 h and stored at − 80 ºC. GST-fused proteins (10 μl) were incubated with 100 ng of the recombinant p35/Cdk5 protein complex (Cell Signaling Technology). For input, gels were stained with Coomassie blue solution (0.1% (w/v) Coomassie blue, 50% (v/v) methanol, 10% (v/v) acetic acid) for 15 min under stirring at room temperature, and then faded in a solution containing 20% (v/v) methanol and 10% (v/v) acetic acid with shaking.
Quantitative reverse transcription-polymerase chain reaction analysis. This was performed in total RNA samples, purified from neurons or astrocytes using a commercially available kit (Sigma), utilizing the Power SYBR Green RNA-to-C T 1-Step kit (Applied Biosystems, Township, USA). Reverse transcription was performed for 30 min at 48ºC, and PCR conditions were 10 min at 95°C followed by 40 cycles of 15 s at 95°C plus 1 min at 55°C using the following forward and reserve primers, respectively (Thermo Scientific, Offenbach, Germany), 5ʹ-GCAGGACATGGATTTGATTGA-3ʹ and 5ʹ-GTCAAACACTTCTCGACTTAC-3ʹ (Nrf2), 5ʹ-GGAGCAATAAGAAATGCTTGCCA-3ʹ and 5ʹ-GGAGCCTCAAAATCTTC CTCATA-3ʹ (Cul3), 5ʹ-AGCACAGGGTGACAGAAGAG-3ʹ and 5ʹ-GAGGGACTC TGGTCTTTGTG-3ʹ (Gclc), 5ʹ-GGCACAAGGACGTGCTCAAGT-3ʹ and 5ʹ-TGCA GAGTTTCAAGAACATCG-3ʹ (Ho-1), 5ʹ-GGGGACATGAACGTCATTCTCT-3ʹ and 5ʹ-AAGACCTGGAAGCCACAGAAGC-3ʹ (Nqo1), 5ʹ-ACCAGCAGTTTCAGGAACC ATTT-3ʹ and 5ʹ-GCGCCAAGATTCACCTTCCCT-3ʹ (Cop9S5), 5ʹ-GCTTTCTGA CAAGGAGCAGCTTC-3ʹ and 5ʹ-CCACTGGAAGCTGGAGGGAGTT-3ʹ (Cand1), 5ʹ-GGGTGTGAACCACGAGAAAT-3ʹ and 5ʹ-CCTTCCACGATGCCAAAGTT-3ʹ (Gapdh). The mRNA abundance of each transcript was normalized to the Gapdh mRNA abundance obtained in the same sample. The relative mRNA levels were calculated using the ΔΔCt method, and were expressed as the fold change between sample and calibrator.
Reverse transcription and polymerase chain reaction (RT-PCR).
Total RNA was purified from neurons and astrocytes using a commercially available kit (Sigma, Saint Louis, MO, USA). NR1, NR2A and NR2B mRNA expression were analyzed by electrophoresis in 4% agarose gel after RT-PCR, using the following forward and reverse oligonucleotides, respectively: 5′-CTGCTGACATTCG CCCTGCTT-3′ and 5′-ATCTCAAACCAGACGCTGGACT-3′ for NR1, 5′-CTCA TCCCCAAAGAGTTTCCATC-3′ and 5′-CCTATCATTCCATTCCACACATTG-3′ for NR2A, 5′-CCTTTCCGCTTTGGGACTGTG-3′ and 5′-GTTCTTCCATCTCCCCA TCTCCA for NR2B and 5'-GGGTGTGAACACGAGAAAT-3′ and 5′-CCTTCCACG ATGCCAAAGTT-3′ for GAPDH. Reverse transcription was performed at 48°C for 50 min, and PCR conditions were 10 min at 95 ºC, 35 cycles of 30 s at 95 ºC, 30 s at 52°C and 1 min at 72 ºC. Final extension was carried out for 10 min at 72 ºC. In no case was a band detected by PCR without reverse transcription.
Epifluorescence microscopy. Astrocytes grown on glass coverslips were transfected and treated as indicated. Then, the cells were fixed with 4% (v/v in PBS) paraformaldehyde for 20 min and incubated with DAPI (30 μM; Sigma). Coverslips were washed and mounted in SlowFade light antifade reagent (Molecular Probes, Eugene, OR, USA) on glass slides for fluorescence microphotographs at × 40 magnification using a Nikon Eclipse Ti-E (Tokyo, Japan). Approximately 150 GFP + / DAPI + nuclei were quantified in at least five microscopic fields.
Inmunocytochemistry. Cells grown on glass coverslips were fixed with 4% paraformaldehyde (v/v in PBS) for 10 min, rinsed with PBS and permeabilized for 5 min with 0.2% Triton-X-100. Cells were then incubated for 1 h at room temperature in PBS containing blocking solution (0.2% Triton-X-100, 5% goat serum, bovine serum albumin (BSA) 1%) and kept overnight at 4°C with anti-GFAP (1:250 dilution), anti-Map2 (1/500 dilution) anti-Iba-1 (1:250 dilution; Wako, 019-19741) and anti-O4 (1:150 dilution; Millipore, MAB345). After washing with PBS, cells were incubated with the secondary antibodies Alexa-488-conjugated goat anti-rabbit (1:500 dilution; Molecular Probes, Invitrogen), Alexa 594-conjugated goat anti-mouse (1:500 dilution; Molecular Probes, Invitrogen), Cy2-conjugated goat anti-mouse (1:500 dilution; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and Cy3-conjugated goat anti-rabbit (1:500 dilution; Jackson ImmunoResearch Laboratories) for 1 h at room temperatura, followed by DAPI (30 μM; Sigma) staining. Coverslips were washed and mounted in SlowFade light antifade reagent (Molecular Probes) on glass slides for fluorescence microphotographs at × 40 magnification using a Nikon Inverted microscope (Eclipse Ti-E, Tokyo, Japan). For the assessment of GFP + nuclear localization, astrocytes were fixed, mounted and stained with DAPI as above for fluorescence microphotographs (×40 magnification). Approximately 150 GFP + /DAPI + nuclei were quantified in at least five microscopic fields.
Protein determinations. Cells were lysed in 0.1 M NaOH and used for the determination of protein concentrations by either the Lowry method 55 or the BCA
